To the best of our knowledge, miR-1269b polymorphism has never been investigated in any premalignant lesions or cancers.
This is the first study to find that the genetic variants of miR-1269b are associated with a decreased risk of oral premalignant lesions, oral cancer, and pharyngeal cancer.